News

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products ...
In this article, we are going to take a look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands against other Monday’s best performers. The stock market kicked off the trading week on ...
The action, which is captioned New England Teamsters Pension Fund v. West Pharmaceutical Services, Inc., No. 25-cv-02285 (E.D. Pa.) asserts claims under Sections 10(b) and 20(a) of the Securities ...
The action, which is captioned New England Teamsters Pension Fund v. West Pharmaceutical Services, Inc., No. 25-cv-02285 (E.D. Pa.) asserts claims under Sections 10(b) and 20(a) of the Securities ...
School of Electronics and Information, Northwestern Polytechnical University, Xi’an 710129, P. R. China Research & Development Institute of Northwestern Polytechnical University in Shenzhen, Sanhang ...
The objective of the Fund is to track the performance of the FTSE World Index - Health Care (the “Benchmark Index”) on a net total return basis before fees and expenses are applied ... companies ...
Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Phathom Pharmaceuticals, Inc. before investing. In this article, we go over a few ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the distribution to be paid on April 30, 2025 and cumulative distributions paid fiscal year-to-date. In March 2015 ...
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...